'Unique' Issues Cause FDA To Temporarily Suspend Ban On Juul Cigarettes

Indonesia Berita Berita

'Unique' Issues Cause FDA To Temporarily Suspend Ban On Juul Cigarettes
Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 NBCLA
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 59%

The FDA issued the initial order banning Juul sales on June 23. A day later, a federal appeals court temporarily blocked the government ban.

On Thursday, the FDA ordered Juul, which has long been cited as the reason for the national rise in teen vaping, to pull its e-cigarette products from U.S. markets.

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

NBCLA /  🏆 319. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

FDA temporarily suspends order banning Juul cigarettesFDA temporarily suspends order banning Juul cigarettesThe Food and Drug Administration said on Twitter that the stay temporarily suspends the marketing denial order while it conducts further review, but does not rescind it.
Baca lebih lajut »

FDA temporarily suspends order banning Juul cigarettesFDA temporarily suspends order banning Juul cigarettesThe Food and Drug Administration issued an administrative stay Tuesday on the order it issued last month for vaping company Juul to pull its electronic cigarettes from the market.
Baca lebih lajut »

Juul Can Keep Selling Its Products in U.S. While It Appeals Ban, FDA SaysJuul Can Keep Selling Its Products in U.S. While It Appeals Ban, FDA SaysThe FDA says it will allow Juul to stay on the U.S. market while the e-cigarette maker appeals the agency’s ban
Baca lebih lajut »

FDA decision on Eisai, Biogen Alzheimer's drug due in JanuaryFDA decision on Eisai, Biogen Alzheimer's drug due in JanuaryThe U.S. Food and Drug Administration will expedite its review of Eisai Co Ltd's and Biogen Inc's experimental Alzheimer's drug lecanemab, with a decision due by Jan 6, 2023, the companies said on Tuesday.
Baca lebih lajut »

FDA Warns Against Baby Neck Floats After A Reported DeathFDA Warns Against Baby Neck Floats After A Reported DeathThe organization urged caregivers to stop using inflatable neck floats, especially with babies who have developmental delays or special needs.
Baca lebih lajut »

Serious Illnesses From Daily Harvest Lentil Crumbles, FDA Investigates - MedicineNet Health NewsSerious Illnesses From Daily Harvest Lentil Crumbles, FDA Investigates - MedicineNet Health NewsFallout is mounting for the food delivery service Daily Harvest, which has voluntarily recalled a frozen food product suspected of sickening hundreds of customers in at least 26 states.
Baca lebih lajut »



Render Time: 2025-03-01 08:24:00